The DCA Vantage® Analyzer is a multi-parameter, point-of-care analyzer for monitoring glycemic control in patients with diabetes and detecting early kidney disease.
Easy to use and implement
Improve patient outcomes and operational costs
Failsafe measures for audit risk mitigation
Results you can trust
Hemoglobin A1c (HbA1c)
Albumin
Creatinine
Albumin-to-Creatinine (A:C) Ratio Results
Overview |
|
System Description | Point-of-care immunoassay analyzer |
Quantitative Tests | Hemoglobin A1c (whole blood): Range: 2.5% to 14% (4mmol/mol to 130 mmol/mol) Microalbumin/Creatinine (urine): Single test reports all three results for: Albumin: 5 to 300 mg/L; Creatinine: 15 to 500 mg/dL (1.3 to 44.2 mmol/L); Albumin-to Creatinine Ratio: 1 to 2000 mg/g (0.11 to 226 mg/mmol) |
Test Format | Self-contained immunoassay cartridges |
Test Measurement | Automatic, optional transmission |
Test Method | HbA1c: monoclonal antibody agglutination reaction |
Time to Test Results | HbA1c - 6 minutes |
A:C Ratio - 7 minutes | |
Test Handling | |
Sample Volume | HbA1c - 1µL whole blood |
Sample Preparation | No pretreatment; no pipetting required |
Sample ID/Operator ID Entry | Optional; via touch screen or bar code reader |
Calibration | |
Calibration | Lot-specific calibration card provides automatic calibration with every cartridge Traceable to International Federation of Clinical Chemistry (IFCC) reference materials and test methods for measurement of HbA1c |
Onboard Computer | |
Storage Capacity/Memory | 4000 patient and/or control records |
Display | Color touch screen with 1/4 VGA resolution |
Data Export | Via USB flash drive to PC or direct to LIS/HIS or data manager, if interfaced |
Quality Control/Compliance |
|
Flexible QC Scheduling | None, Automatic Reminders or Required |
QC Testing | Optional lockout if schedule not followed or QC fails |
User/Operator Access | Restricted, if desired, to protect patient and QC data and prevent unauthorized use |
Matching Lab Results/ |
|
Reference Ranges | User-definable reference ranges available for HbA1c |
Computer/Peripheral Interfaces |
|
Serial Port | RS232, ASTM |
Ethernet Connection | ASTM or POCT1-A2 |
Bi-Directional Capabilities | ASTM: Remote computer can be set up to lock out patient tests |
USB-Port | Standard USB 2.0 |
External Bar Code Reader (optional) | Serial (9 pin) |
Onboard Printer | 54 mm (2 in) width, thermal/label stock |
External Printer | Supports standard PCL printer interface via USB port |
General | |
Dimensions | 9.0 (h) x 11.5 (w) x 10.5 (d) inches 25.4 (h) x 28.7 (w) x 27.7 (d) cm |
Weight | 3.88 kg (9.0 lb) |
Power Requirements | 100 to 240 VAC; 50/60 Hz |
Line Leakage Current | <0.3 mA in normal condition |
Maximum Power Input | 70 VA; 30 watts |
Ambient Operating Temperature | 18°C to 30°C (64°F to 86°F) (Albumin) |
Operating Temperature | 5°C to 40°C (41°F to 104°F); |
Safety | TUV SUD with CB Scheme, CSA-C22.2, |
EMC Emissions/Immunity | FCC 47: Part 15 (Class B), |
References
Crocker, et al. Patient satisfaction with point-of-care laboratory testing: report of a quality improvement program in an ambulatory practice of an academic medical center.
Clinica Chimica Acta. 2013;424:8-11.
Schnell, et al. Impact of HbA1c testing at point of care on diabetes management. Journal of Diabetes Science and Technology. 2017;11(3):611-17.
Petersen J, et al. Effect of point-of-care on maintenance of glycemic control as measured by A1C. Diabetes Care. 2007 Mar;30(3).
Felix O. Omoruyi, Gul M. Mustafa, Anthony O. Okorodudu, John R. Petersen. Clinica Chimica Acta 413 (2012) 625–629; evaluation of the performance of urine albumin, creatinine and albumin–creatinine ratio assay on two POCT analyzers relative to a central laboratory method.
Weykamp et al. Clin Chemisty 61:5; 752-759
